| 摘要 |
ANTINEOPLASTIC COMBINATIONS CONTAINING HKI-272 AND VINORELBINE A combination of HKI-272 compound and a vinorelbine compound in the treatment of a neoplasm is disclosed. Regimens, kits, and methods for treatment of neoplasm, including breast cancer including metastatic breast cancer, and lung cancer, using this combination, optionally in combination with other anti-neoplastic agents, or immune modulators are also disclosed. |
